Chemoinformaics analysis of Tetradeca-4,6-diene-8,10,12-triyne-1-ol
Molecular Weight | 214.264 | nRot | 4 |
Heavy Atom Molecular Weight | 200.152 | nRig | 7 |
Exact Molecular Weight | 214.099 | nRing | 1 |
Solubility: LogS | -3.528 | nHRing | 1 |
Solubility: LogP | 2.686 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 14 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 34.3191 |
nHD | 1 | BPOL | 15.7809 |
QED | 0.561 |
Synth | 4.562 |
Natural Product Likeliness | 3.417 |
NR-PPAR-gamma | 0.824 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0.001 |
HIA | 0.433 |
CACO-2 | -4.002 |
MDCK | 0.0000358 |
BBB | 0.005 |
PPB | 1.01208 |
VDSS | 1.307 |
FU | 0.0252309 |
CYP1A2-inh | 0.641 |
CYP1A2-sub | 0.121 |
CYP2c19-inh | 0.874 |
CYP2c19-sub | 0.648 |
CYP2c9-inh | 0.855 |
CYP2c9-sub | 0.951 |
CYP2d6-inh | 0.738 |
CYP2d6-sub | 0.756 |
CYP3a4-inh | 0.8 |
CYP3a4-sub | 0.313 |
CL | 8.353 |
T12 | 0.288 |
hERG | 0.002 |
Ames | 0.497 |
ROA | 0.354 |
SkinSen | 0.944 |
Carcinogencity | 0.513 |
EI | 0.982 |
Respiratory | 0.855 |
NR-Aromatase | 0.958 |
Antiviral | Yes |
Prediction | 0.570371 |